EMA Issues Updated Pediatric Pharmacovigilance Guidance

International Pharmaceutical Regulatory Monitor
A A
The European Medicines Agency’s updated guidelines on good pharmacovigilance practices took effect Nov. 8 — urging sponsors to pay particular attention to symptoms subjects may be unable to communicate.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor

Buy This Article Now

Add this article to your cart for $40.00